TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 19, No. 4 February 19, 2013
__________________________________________________________
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None Submitted for this issue.
__________________________________________________________
UPCOMING MEETINGS & EVENTS
General info on upcoming meetings:
http://tf7.org/meetings.htm
*** *** *** ***
The Amsterdam ISTH 2013 Congress Late Breaking Abstract Deadline is May 1, 2013. For more information:
http://www.isth2013.org/abstract-submission/
_________________________________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 19, No. 4 February 19, 2013
(The next issue will be on March 1, 2013)
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None Submitted for this issue.
__________________________________________________________
UPCOMING MEETINGS & EVENTS
General info on upcoming meetings:
http://tf7.org/meetings.htm
*** *** *** ***
The Amsterdam ISTH 2013 Congress Late Breaking Abstract Deadline is May 1, 2013. For more information:
http://www.isth2013.org/abstract-submission/
_________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1jaC2ldmGyTOtixzKpJomjd/
Aberg M, Siegbahn A (2013) Tissue Factor non-coagulant signalling - molecular mechanisms and biological consequences with focus on cell migration and apoptosis. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/23384027
Alexandru N, Popov D, Dragan E, Andrei E, Georgescu A (2013) Circulating endothelial progenitor cell and platelet microparticle impact on platelet activation in hypertension associated with hypercholesterolemia. PLoS One 8:e52058.
http://www.ncbi.nlm.nih.gov/pubmed/23372649
Alioglu B, Kilic N, Simsek E, Dallar Y (2012) Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor and thrombomodulin levels in children with hypothyroidism. J Clin Res Pediatr Endocrinol 4:146-150.
http://www.ncbi.nlm.nih.gov/pubmed/22985614
Amirkhosravi A, Bigsby G 4th, Desai H, Rivera-Amaya M, Coll E, Robles-Carrillo L, . . . Francis JL (2013) Blood clotting activation analysis for preoperative differentiation of benign versus malignant ovarian masses. Blood Coagul Fibrinolysis.
http://www.ncbi.nlm.nih.gov/pubmed/23406663
Antoniak S, Owens AP, 3rd, Baunacke M, Williams JC, Lee RD, Weithauser A, . . . Mackman N (2013) PAR-1 contributes to the innate immune response during viral infection. J Clin Invest.
http://www.ncbi.nlm.nih.gov/pubmed/23391721
Arderiu G, Pena E, Aledo R, Badimon L (2012) Tissue factor-Akt signaling triggers microvessel formation. J Thromb Haemost 10:1895-1905.
http://www.ncbi.nlm.nih.gov/pubmed/22784289
Bastarache JA, Sebag SC, Clune JK, Grove BS, Lawson WE, Janz DR, . . . Ware LB (2012) Low levels of tissue factor lead to alveolar haemorrhage, potentiating murine acute lung injury and oxidative stress. Thorax 67:1032-1039.
http://www.ncbi.nlm.nih.gov/pubmed/23033361
Bockeria LA, Kupryashov AA, Samsonova NN (2012) eComment. Recombinant activated factor VII in pediatric cardiac surgery: possibilities and limitations. Interact Cardiovasc Thorac Surg 15:694-695.
http://www.ncbi.nlm.nih.gov/pubmed/22991396
Brekke OL, Waage C, Christiansen D, Fure H, Qu H, Lambris JD, . . . Mollnes TE (2013) The effects of selective complement and CD14 inhibition on the E. coli-induced tissue factor mRNA upregulation, monocyte tissue factor expression, and tissue factor functional activity in human whole blood. Adv Exp Med Biol 735:123-136.
http://www.ncbi.nlm.nih.gov/pubmed/23402023
Brem E, Koyfman A, Foran M (2013) Review of Recently Approved Alternatives to Anticoagulation with Warfarin for Emergency Clinicians. J Emerg Med.
http://www.ncbi.nlm.nih.gov/pubmed/23375217
Butenas S (2013) Comparison of natural and recombinant tissue factor proteins: new insights. Biol Chem.
http://www.ncbi.nlm.nih.gov/pubmed/23412875
Carneiro-Lobo TC, Schaffner F, Disse J, Ostergaard H, Francischetti IM, Monteiro RQ, Ruf W (2012) The tick-derived inhibitor Ixolaris prevents tissue factor signaling on tumor cells. J Thromb Haemost 10:1849-1858.
http://www.ncbi.nlm.nih.gov/pubmed/22823596
Cordazzo C, Neri T, Petrini S, Lombardi S, Balia C, Cianchetti S, . . . Celi A (2013) Angiotensin II induces the generation of procoagulant microparticles by human mononuclear cells via an angiotensin type 2 receptor-mediated pathway. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/23414567
Dewalt RI, Petkovich DA, Zahrt AN, Bruns HA, McDowell SA (2013) Host cell invasion by Staphylococcus aureus stimulates the shedding of microvesicles. Biochem Biophys Res Commun.
http://www.ncbi.nlm.nih.gov/pubmed/23410754
Esmon CT (2013) Molecular circuits in thrombosis and inflammation. Thromb Haemost 109:416-420.
http://www.ncbi.nlm.nih.gov/pubmed/23407677
Francischetti IM, Assumpcao TC, Ma D, Li Y, Vicente EC, Uieda W, Ribeiro JM (2013) The "Vampirome": Transcriptome and Proteome Analysis of the Submaxillary and Accessory Glands of the Vampire Bat Desmodus rotundus, a Vector of Human Rabies. J Proteomics.
http://www.ncbi.nlm.nih.gov/pubmed/23411029
Funderburg NT, Zidar DA, Shive C, Lioi A, Mudd J, Musselwhite LW, . . . Lederman MM (2012) Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome. Blood 120:4599-4608.
http://www.ncbi.nlm.nih.gov/pubmed/23065151
Gudmundsdottir BR, Francis CW, Bjornsdottir AM, Nellbring M, Onundarson PT (2012) Critical role of factors II and X during coumarin anticoagulation and their combined measurement with a new Fiix-prothrombin time. Thromb Res 130:674-681.
http://www.ncbi.nlm.nih.gov/pubmed/22225856
Haffner E, Pietsch U, Fosel T, Lindemann W (2013) [Treatment of a pregnant patient after multiple trauma : Rare combination with thrombotic thrombocytopenic purpura.]. Anaesthesist.
http://www.ncbi.nlm.nih.gov/pubmed/23400712
Hampton AL, Diaz JA, Hawley AE, Wrobleski SK, Wang JG, Lee RD, . . . Myers DD, Jr. (2012) Myeloid cell tissue factor does not contribute to venous thrombogenesis in an electrolytic injury model. Thromb Res 130:640-645.
http://www.ncbi.nlm.nih.gov/pubmed/22192154
Hao F, Wu DD, Xu X, Cui MZ (2012) Histamine induces activation of protein kinase D that mediates tissue factor expression and activity in human aortic smooth muscle cells. Am J Physiol Heart Circ Physiol 303:H1344-1352.
http://www.ncbi.nlm.nih.gov/pubmed/23001835
Harter PN, Dutzmann S, Drott U, Zachskorn C, Hattingen E, Capper D, . . . Mittelbronn M (2013) Anti-tissue factor (TF9-10H10) treatment reduces tumor cell invasiveness in a novel migratory glioma model. Neuropathology.
http://www.ncbi.nlm.nih.gov/pubmed/23384223
Jozwik M (2012) The mechanism of thromboembolism in the course of ovarian hyperstimulation syndrome. Med Wieku Rozwoj 16:269-271.
http://www.ncbi.nlm.nih.gov/pubmed/23378404
Kopyta IA, Emich-Widera E, Balcerzyk A, Niemiec P, Zak I, Pilarska E, . . . Palatynska K (2012) Polymorphisms of genes encoding coagulation factors II, V, VII, and XIII in relation to pediatric ischemic stroke: family-based and case-control study. Neurologist 18:282-286.
http://www.ncbi.nlm.nih.gov/pubmed/22931734
Krysiak R, Zmuda W, Okopien B (2012) The effect of ezetimibe and simvastatin on hemostasis in patients with isolated hypercholesterolemia. Fundam Clin Pharmacol 26:424-431.
http://www.ncbi.nlm.nih.gov/pubmed/21392096
Lambourne MD, Eltringham-Smith LJ, Gataiance S, Arnold DM, Crowther MA, Sheffield WP (2012) Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate. J Thromb Haemost 10:1830-1840.
http://www.ncbi.nlm.nih.gov/pubmed/22817470
Lee R, Williams JC, Mackman N (2012) P2X7 regulation of macrophage tissue factor activity and microparticle generation. J Thromb Haemost 10:1965-1967.
http://www.ncbi.nlm.nih.gov/pubmed/22759201
Livnat T, Shenkman B, Spectre G, Tamarin I, Dardik R, Israeli A, . . . Salomon O (2012) Recombinant factor VIIa treatment for asymptomatic factor VII deficient patients going through major surgery. Blood Coagul Fibrinolysis 23:379-387.
http://www.ncbi.nlm.nih.gov/pubmed/22527290
Mackinder MA, Evans CA, Chowdry J, Staton CA, Corfe BM (2012) Alteration in composition of keratin intermediate filaments in a model of breast cancer progression and the potential to reverse hallmarks of metastasis. Cancer Biomark 12:49-64.
http://www.ncbi.nlm.nih.gov/pubmed/23396250
Maksimovic B, Neretljak I, Vidas Z, Vojtusek IK, Tomulic K, Knotek M (2012) Treatment of bleeding after kidney biopsy with recombinant activated factor VII. Blood Coagul Fibrinolysis 23:241-243.
http://www.ncbi.nlm.nih.gov/pubmed/22395184
McCarthy GC, Allen TK, Habib AS (2012) Pulmonary embolism after administration of recombinant activated Factor VII for major obstetric hemorrhage. J Clin Anesth 24:508-509.
http://www.ncbi.nlm.nih.gov/pubmed/22986324
Mokhtar GM, Tantawy AA, Adly AA, Telbany MA, El Arab SE, Ismail M (2012) A longitudinal prospective study of bleeding diathesis in Egyptian pediatric patients: single-center experience. Blood Coagul Fibrinolysis 23:411-418.
http://www.ncbi.nlm.nih.gov/pubmed/22610136
Motoki Y, Nojima J, Yanagihara M, Tsuneoka H, Matsui T, Yamamoto M, Ichihara K (2012) Anti-phospholipid antibodies contribute to arteriosclerosis in patients with systemic lupus erythematosus through induction of tissue factor expression and cytokine production from peripheral blood mononuclear cells. Thromb Res 130:667-673.
http://www.ncbi.nlm.nih.gov/pubmed/22196362
Nakamura S, Morimoto A, Oh Y, Hayase T, Kashii Y, Gunji Y, Momoi MY (2012) Cost effectiveness of prophylactic treatment with activated prothrombin complex concentrate in a patient with inhibitor-positive hemophilia A. Blood Coagul Fibrinolysis 23:235-237.
http://www.ncbi.nlm.nih.gov/pubmed/22322137
Napolitano M, Giansily-Blaizot M, Dolce A, Schved JF, Auerswald G, Ingerslev J, . . . Mariani G (2013) Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER). Haematologica.
http://www.ncbi.nlm.nih.gov/pubmed/23403322
Ndonwi M, Girard TJ, Broze GJ, Jr. (2012) The C-terminus of tissue factor pathway inhibitor alpha is required for its interaction with factors V and Va. J Thromb Haemost 10:1944-1946.
http://www.ncbi.nlm.nih.gov/pubmed/22738072
Ng C, Silliman CC, Pearl G, Smith W, Manco-Johnson M, Wang M (2013) Treatment of refractory hemorrhage with factor XIII in a patient with hemophilia A with inhibitor. Pediatr Blood Cancer.
http://www.ncbi.nlm.nih.gov/pubmed/23382082
Nigro CL, Wang H, McHugh A, Lattanzio L, Matin R, Harwood C, . . . Crook T (2013) Methylated Tissue Factor Pathway Inhibitor 2 (TFPI2) DNA in Serum Is a Biomarker of Metastatic Melanoma. J Invest Dermatol.
http://www.ncbi.nlm.nih.gov/pubmed/23407390
Okonta KE, Edwin F, Falase B (2012) Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery? Interact Cardiovasc Thorac Surg 15:690-694.
http://www.ncbi.nlm.nih.gov/pubmed/22811512
Oliveira DG, Alvarez-Flores MP, Lopes AR, Chudzinski-Tavassi AM (2012) Functional characterisation of vizottin, the first factor Xa inhibitor purified from the leech Haementeria vizottoi. Thromb Haemost 108:570-578.
http://www.ncbi.nlm.nih.gov/pubmed/22782262
Onwuemene O, Green D, Keith L (2012) Postpartum hemorrhage management in 2012: predicting the future. Int J Gynaecol Obstet 119:3-5.
http://www.ncbi.nlm.nih.gov/pubmed/22867727
Podda G, Femia EA, Pugliano M, Cattaneo M (2012) Congenital defects of platelet function. Platelets 23:552-563.
http://www.ncbi.nlm.nih.gov/pubmed/23020613
Prabhakar P, De T, Nagaraja D, Christopher R (2012) The intron 7 -33T>C polymorphism in TFPI gene and cerebral venous thrombosis: evidence for a protective role. Thromb Res 130:687-689.
http://www.ncbi.nlm.nih.gov/pubmed/22836130
Raps M, Helmerhorst FM, Fleischer K, Dahm AE, Rosendaal FR, Rosing J, . . . van Vliet HA (2013) The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI.
Thromb Haemost 109.
http://www.ncbi.nlm.nih.gov/pubmed/23407778
Rautou PE, Mackman N (2013) Microvesicles as risk markers for venous thrombosis. Expert Rev Hematol 6:91-101.
http://www.ncbi.nlm.nih.gov/pubmed/23373784
Rong JX, Blachford C, Feig JE, Bander I, Mayne J, Kusunoki J, . . . Fisher EA (2013) ACAT inhibition reduces the progression of preexisting, advanced atherosclerotic mouse lesions without plaque or systemic toxicity. Arterioscler Thromb Vasc Biol 33:4-12.
http://www.ncbi.nlm.nih.gov/pubmed/23139293
Siegal DM, Cuker A (2013) Reversal of novel oral anticoagulants in patients with major bleeding. J Thromb Thrombolysis.
http://www.ncbi.nlm.nih.gov/pubmed/23389753
Sosothikul D, Kittikalayawong Y, Aungbamnet P, Buphachat C, Seksarn P (2012) Reference values for thrombotic markers in children. Blood Coagul Fibrinolysis 23:208-211.
http://www.ncbi.nlm.nih.gov/pubmed/22322138
Strak M, Hoek G, Steenhof M, Kilinc E, Godri KJ, Gosens I, . . . Janssen NA (2013) Components of ambient air pollution affect thrombin generation in healthy humans: the RAPTES project. Occup Environ Med.
http://www.ncbi.nlm.nih.gov/pubmed/23378445
Stravitz RT, Bowling R, Bradford RL, Key NS, Glover S, Thacker LR, Gabriel DA (2013) Role of procoagulant microparticles in mediating complications and outcome of acute liver injury/Acute liver failure. Hepatology.
http://www.ncbi.nlm.nih.gov/pubmed/23389887
Sun L, Liu Y, Lin S, Shang J, Liu J, Li J, . . . Zhang L (2013) Early growth response gene-1 and hypoxia-inducible factor-1alpha affect tumor metastasis via regulation of tissue factor. Acta Oncol.
http://www.ncbi.nlm.nih.gov/pubmed/23409769
Suzuki A, Miyawaki Y, Okuyama E, Murata M, Ando Y, Kato I, . . . Kojima T (2013) Ribavirin-induced intracellular GTP depletion activates transcription elongation in coagulation factor VII gene expression. Biochem J 449:231-239.
http://www.ncbi.nlm.nih.gov/pubmed/23050902
Thaler J, Ay C, Mackman N, Metz-Schimmerl S, Stift J, Kaider A, . . . Pabinger I (2013) Microparticle-associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features. Eur J Clin Invest 43:277-285.
http://www.ncbi.nlm.nih.gov/pubmed/23398637
Williams FM, Carter AM, Hysi PG, Surdulescu G, Hodgkiss D, Soranzo N, . . . Spector TD (2013) Ischemic stroke is associated with the ABO locus: The EuroCLOT study. Ann Neurol 73:16-31.
http://www.ncbi.nlm.nih.gov/pubmed/23381943
Woo HI, Park IA, Lee KO, Kim SH, Kim HJ (2012) Combined congenital dysfibrinogenemia and factor VII deficiency from mutations in the FGB and F7 genes. Blood Coagul Fibrinolysis 23:355-358.
http://www.ncbi.nlm.nih.gov/pubmed/22576285
Yates KR, Welsh J, Udegbunam NO, Greenman J, Maraveyas A, Madden LA (2012) Duramycin exhibits antiproliferative properties and induces apoptosis in tumour cells. Blood Coagul Fibrinolysis 23:396-401.
http://www.ncbi.nlm.nih.gov/pubmed/22543977
Yuana Y, Osanto S, Bertina RM (2012) Use of immuno-magnetic beads for direct capture of nanosized microparticles from plasma. Blood Coagul Fibrinolysis 23:244-250.
http://www.ncbi.nlm.nih.gov/pubmed/22343682
Zabczyk M, Butenas S, Plicner D, Fijorek K, Sadowski J, Undas A (2012) Factors associated with the presence of circulating active tissue factor and activated factor XI in stable angina patients. Blood Coagul Fibrinolysis 23:189-194.
http://www.ncbi.nlm.nih.gov/pubmed/22343680
Zhang X, Glunz PW, Jiang W, Schmitt A, Newman M, Barbera FA, . . . Scott Priestley E (2013) Design and synthesis of bicyclic pyrazinone and pyrimidinone amides as potent TF-FVIIa inhibitors. Bioorg Med Chem Lett.
http://www.ncbi.nlm.nih.gov/pubmed/23416003
Zhao Y, Fu Y, Hu J, Liu Y, Yin X (2013) The effect of tissue factor pathway inhibitor on the expression of monocyte chemotactic protein-3 and IkappaB-alpha stimulated by tumour necrosis factor-alpha in cultured vascular smooth muscle cells. Arch Cardiovasc Dis 106:4-11.
http://www.ncbi.nlm.nih.gov/pubmed/23374966
Zhou H, Chen D, Xie H, Xia L, Wang T, Yuan W, Yan J (2012) Activation of MAPKs in the anti-beta2GPI/beta2GPI-induced tissue factor expression through TLR4/IRAKs pathway in THP-1 cells. Thromb Res 130:e229-235.
http://www.ncbi.nlm.nih.gov/pubmed/22940059
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1jaC2ldmGyTOtixzKpJomjd/
Aberg M, Siegbahn A (2013) Tissue Factor non-coagulant signalling - molecular mechanisms and biological consequences with focus on cell migration and apoptosis. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/23384027
Alexandru N, Popov D, Dragan E, Andrei E, Georgescu A (2013) Circulating endothelial progenitor cell and platelet microparticle impact on platelet activation in hypertension associated with hypercholesterolemia. PLoS One 8:e52058.
http://www.ncbi.nlm.nih.gov/pubmed/23372649
Alioglu B, Kilic N, Simsek E, Dallar Y (2012) Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor and thrombomodulin levels in children with hypothyroidism. J Clin Res Pediatr Endocrinol 4:146-150.
http://www.ncbi.nlm.nih.gov/pubmed/22985614
Amirkhosravi A, Bigsby G 4th, Desai H, Rivera-Amaya M, Coll E, Robles-Carrillo L, . . . Francis JL (2013) Blood clotting activation analysis for preoperative differentiation of benign versus malignant ovarian masses. Blood Coagul Fibrinolysis.
http://www.ncbi.nlm.nih.gov/pubmed/23406663
Antoniak S, Owens AP, 3rd, Baunacke M, Williams JC, Lee RD, Weithauser A, . . . Mackman N (2013) PAR-1 contributes to the innate immune response during viral infection. J Clin Invest.
http://www.ncbi.nlm.nih.gov/pubmed/23391721
Arderiu G, Pena E, Aledo R, Badimon L (2012) Tissue factor-Akt signaling triggers microvessel formation. J Thromb Haemost 10:1895-1905.
http://www.ncbi.nlm.nih.gov/pubmed/22784289
Bastarache JA, Sebag SC, Clune JK, Grove BS, Lawson WE, Janz DR, . . . Ware LB (2012) Low levels of tissue factor lead to alveolar haemorrhage, potentiating murine acute lung injury and oxidative stress. Thorax 67:1032-1039.
http://www.ncbi.nlm.nih.gov/pubmed/23033361
Bockeria LA, Kupryashov AA, Samsonova NN (2012) eComment. Recombinant activated factor VII in pediatric cardiac surgery: possibilities and limitations. Interact Cardiovasc Thorac Surg 15:694-695.
http://www.ncbi.nlm.nih.gov/pubmed/22991396
Brekke OL, Waage C, Christiansen D, Fure H, Qu H, Lambris JD, . . . Mollnes TE (2013) The effects of selective complement and CD14 inhibition on the E. coli-induced tissue factor mRNA upregulation, monocyte tissue factor expression, and tissue factor functional activity in human whole blood. Adv Exp Med Biol 735:123-136.
http://www.ncbi.nlm.nih.gov/pubmed/23402023
Brem E, Koyfman A, Foran M (2013) Review of Recently Approved Alternatives to Anticoagulation with Warfarin for Emergency Clinicians. J Emerg Med.
http://www.ncbi.nlm.nih.gov/pubmed/23375217
Butenas S (2013) Comparison of natural and recombinant tissue factor proteins: new insights. Biol Chem.
http://www.ncbi.nlm.nih.gov/pubmed/23412875
Carneiro-Lobo TC, Schaffner F, Disse J, Ostergaard H, Francischetti IM, Monteiro RQ, Ruf W (2012) The tick-derived inhibitor Ixolaris prevents tissue factor signaling on tumor cells. J Thromb Haemost 10:1849-1858.
http://www.ncbi.nlm.nih.gov/pubmed/22823596
Cordazzo C, Neri T, Petrini S, Lombardi S, Balia C, Cianchetti S, . . . Celi A (2013) Angiotensin II induces the generation of procoagulant microparticles by human mononuclear cells via an angiotensin type 2 receptor-mediated pathway. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/23414567
Dewalt RI, Petkovich DA, Zahrt AN, Bruns HA, McDowell SA (2013) Host cell invasion by Staphylococcus aureus stimulates the shedding of microvesicles. Biochem Biophys Res Commun.
http://www.ncbi.nlm.nih.gov/pubmed/23410754
Esmon CT (2013) Molecular circuits in thrombosis and inflammation. Thromb Haemost 109:416-420.
http://www.ncbi.nlm.nih.gov/pubmed/23407677
Francischetti IM, Assumpcao TC, Ma D, Li Y, Vicente EC, Uieda W, Ribeiro JM (2013) The "Vampirome": Transcriptome and Proteome Analysis of the Submaxillary and Accessory Glands of the Vampire Bat Desmodus rotundus, a Vector of Human Rabies. J Proteomics.
http://www.ncbi.nlm.nih.gov/pubmed/23411029
Funderburg NT, Zidar DA, Shive C, Lioi A, Mudd J, Musselwhite LW, . . . Lederman MM (2012) Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome. Blood 120:4599-4608.
http://www.ncbi.nlm.nih.gov/pubmed/23065151
Gudmundsdottir BR, Francis CW, Bjornsdottir AM, Nellbring M, Onundarson PT (2012) Critical role of factors II and X during coumarin anticoagulation and their combined measurement with a new Fiix-prothrombin time. Thromb Res 130:674-681.
http://www.ncbi.nlm.nih.gov/pubmed/22225856
Haffner E, Pietsch U, Fosel T, Lindemann W (2013) [Treatment of a pregnant patient after multiple trauma : Rare combination with thrombotic thrombocytopenic purpura.]. Anaesthesist.
http://www.ncbi.nlm.nih.gov/pubmed/23400712
Hampton AL, Diaz JA, Hawley AE, Wrobleski SK, Wang JG, Lee RD, . . . Myers DD, Jr. (2012) Myeloid cell tissue factor does not contribute to venous thrombogenesis in an electrolytic injury model. Thromb Res 130:640-645.
http://www.ncbi.nlm.nih.gov/pubmed/22192154
Hao F, Wu DD, Xu X, Cui MZ (2012) Histamine induces activation of protein kinase D that mediates tissue factor expression and activity in human aortic smooth muscle cells. Am J Physiol Heart Circ Physiol 303:H1344-1352.
http://www.ncbi.nlm.nih.gov/pubmed/23001835
Harter PN, Dutzmann S, Drott U, Zachskorn C, Hattingen E, Capper D, . . . Mittelbronn M (2013) Anti-tissue factor (TF9-10H10) treatment reduces tumor cell invasiveness in a novel migratory glioma model. Neuropathology.
http://www.ncbi.nlm.nih.gov/pubmed/23384223
Jozwik M (2012) The mechanism of thromboembolism in the course of ovarian hyperstimulation syndrome. Med Wieku Rozwoj 16:269-271.
http://www.ncbi.nlm.nih.gov/pubmed/23378404
Kopyta IA, Emich-Widera E, Balcerzyk A, Niemiec P, Zak I, Pilarska E, . . . Palatynska K (2012) Polymorphisms of genes encoding coagulation factors II, V, VII, and XIII in relation to pediatric ischemic stroke: family-based and case-control study. Neurologist 18:282-286.
http://www.ncbi.nlm.nih.gov/pubmed/22931734
Krysiak R, Zmuda W, Okopien B (2012) The effect of ezetimibe and simvastatin on hemostasis in patients with isolated hypercholesterolemia. Fundam Clin Pharmacol 26:424-431.
http://www.ncbi.nlm.nih.gov/pubmed/21392096
Lambourne MD, Eltringham-Smith LJ, Gataiance S, Arnold DM, Crowther MA, Sheffield WP (2012) Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate. J Thromb Haemost 10:1830-1840.
http://www.ncbi.nlm.nih.gov/pubmed/22817470
Lee R, Williams JC, Mackman N (2012) P2X7 regulation of macrophage tissue factor activity and microparticle generation. J Thromb Haemost 10:1965-1967.
http://www.ncbi.nlm.nih.gov/pubmed/22759201
Livnat T, Shenkman B, Spectre G, Tamarin I, Dardik R, Israeli A, . . . Salomon O (2012) Recombinant factor VIIa treatment for asymptomatic factor VII deficient patients going through major surgery. Blood Coagul Fibrinolysis 23:379-387.
http://www.ncbi.nlm.nih.gov/pubmed/22527290
Mackinder MA, Evans CA, Chowdry J, Staton CA, Corfe BM (2012) Alteration in composition of keratin intermediate filaments in a model of breast cancer progression and the potential to reverse hallmarks of metastasis. Cancer Biomark 12:49-64.
http://www.ncbi.nlm.nih.gov/pubmed/23396250
Maksimovic B, Neretljak I, Vidas Z, Vojtusek IK, Tomulic K, Knotek M (2012) Treatment of bleeding after kidney biopsy with recombinant activated factor VII. Blood Coagul Fibrinolysis 23:241-243.
http://www.ncbi.nlm.nih.gov/pubmed/22395184
McCarthy GC, Allen TK, Habib AS (2012) Pulmonary embolism after administration of recombinant activated Factor VII for major obstetric hemorrhage. J Clin Anesth 24:508-509.
http://www.ncbi.nlm.nih.gov/pubmed/22986324
Mokhtar GM, Tantawy AA, Adly AA, Telbany MA, El Arab SE, Ismail M (2012) A longitudinal prospective study of bleeding diathesis in Egyptian pediatric patients: single-center experience. Blood Coagul Fibrinolysis 23:411-418.
http://www.ncbi.nlm.nih.gov/pubmed/22610136
Motoki Y, Nojima J, Yanagihara M, Tsuneoka H, Matsui T, Yamamoto M, Ichihara K (2012) Anti-phospholipid antibodies contribute to arteriosclerosis in patients with systemic lupus erythematosus through induction of tissue factor expression and cytokine production from peripheral blood mononuclear cells. Thromb Res 130:667-673.
http://www.ncbi.nlm.nih.gov/pubmed/22196362
Nakamura S, Morimoto A, Oh Y, Hayase T, Kashii Y, Gunji Y, Momoi MY (2012) Cost effectiveness of prophylactic treatment with activated prothrombin complex concentrate in a patient with inhibitor-positive hemophilia A. Blood Coagul Fibrinolysis 23:235-237.
http://www.ncbi.nlm.nih.gov/pubmed/22322137
Napolitano M, Giansily-Blaizot M, Dolce A, Schved JF, Auerswald G, Ingerslev J, . . . Mariani G (2013) Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER). Haematologica.
http://www.ncbi.nlm.nih.gov/pubmed/23403322
Ndonwi M, Girard TJ, Broze GJ, Jr. (2012) The C-terminus of tissue factor pathway inhibitor alpha is required for its interaction with factors V and Va. J Thromb Haemost 10:1944-1946.
http://www.ncbi.nlm.nih.gov/pubmed/22738072
Ng C, Silliman CC, Pearl G, Smith W, Manco-Johnson M, Wang M (2013) Treatment of refractory hemorrhage with factor XIII in a patient with hemophilia A with inhibitor. Pediatr Blood Cancer.
http://www.ncbi.nlm.nih.gov/pubmed/23382082
Nigro CL, Wang H, McHugh A, Lattanzio L, Matin R, Harwood C, . . . Crook T (2013) Methylated Tissue Factor Pathway Inhibitor 2 (TFPI2) DNA in Serum Is a Biomarker of Metastatic Melanoma. J Invest Dermatol.
http://www.ncbi.nlm.nih.gov/pubmed/23407390
Okonta KE, Edwin F, Falase B (2012) Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery? Interact Cardiovasc Thorac Surg 15:690-694.
http://www.ncbi.nlm.nih.gov/pubmed/22811512
Oliveira DG, Alvarez-Flores MP, Lopes AR, Chudzinski-Tavassi AM (2012) Functional characterisation of vizottin, the first factor Xa inhibitor purified from the leech Haementeria vizottoi. Thromb Haemost 108:570-578.
http://www.ncbi.nlm.nih.gov/pubmed/22782262
Onwuemene O, Green D, Keith L (2012) Postpartum hemorrhage management in 2012: predicting the future. Int J Gynaecol Obstet 119:3-5.
http://www.ncbi.nlm.nih.gov/pubmed/22867727
Podda G, Femia EA, Pugliano M, Cattaneo M (2012) Congenital defects of platelet function. Platelets 23:552-563.
http://www.ncbi.nlm.nih.gov/pubmed/23020613
Prabhakar P, De T, Nagaraja D, Christopher R (2012) The intron 7 -33T>C polymorphism in TFPI gene and cerebral venous thrombosis: evidence for a protective role. Thromb Res 130:687-689.
http://www.ncbi.nlm.nih.gov/pubmed/22836130
Raps M, Helmerhorst FM, Fleischer K, Dahm AE, Rosendaal FR, Rosing J, . . . van Vliet HA (2013) The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI.
Thromb Haemost 109.
http://www.ncbi.nlm.nih.gov/pubmed/23407778
Rautou PE, Mackman N (2013) Microvesicles as risk markers for venous thrombosis. Expert Rev Hematol 6:91-101.
http://www.ncbi.nlm.nih.gov/pubmed/23373784
Rong JX, Blachford C, Feig JE, Bander I, Mayne J, Kusunoki J, . . . Fisher EA (2013) ACAT inhibition reduces the progression of preexisting, advanced atherosclerotic mouse lesions without plaque or systemic toxicity. Arterioscler Thromb Vasc Biol 33:4-12.
http://www.ncbi.nlm.nih.gov/pubmed/23139293
Siegal DM, Cuker A (2013) Reversal of novel oral anticoagulants in patients with major bleeding. J Thromb Thrombolysis.
http://www.ncbi.nlm.nih.gov/pubmed/23389753
Sosothikul D, Kittikalayawong Y, Aungbamnet P, Buphachat C, Seksarn P (2012) Reference values for thrombotic markers in children. Blood Coagul Fibrinolysis 23:208-211.
http://www.ncbi.nlm.nih.gov/pubmed/22322138
Strak M, Hoek G, Steenhof M, Kilinc E, Godri KJ, Gosens I, . . . Janssen NA (2013) Components of ambient air pollution affect thrombin generation in healthy humans: the RAPTES project. Occup Environ Med.
http://www.ncbi.nlm.nih.gov/pubmed/23378445
Stravitz RT, Bowling R, Bradford RL, Key NS, Glover S, Thacker LR, Gabriel DA (2013) Role of procoagulant microparticles in mediating complications and outcome of acute liver injury/Acute liver failure. Hepatology.
http://www.ncbi.nlm.nih.gov/pubmed/23389887
Sun L, Liu Y, Lin S, Shang J, Liu J, Li J, . . . Zhang L (2013) Early growth response gene-1 and hypoxia-inducible factor-1alpha affect tumor metastasis via regulation of tissue factor. Acta Oncol.
http://www.ncbi.nlm.nih.gov/pubmed/23409769
Suzuki A, Miyawaki Y, Okuyama E, Murata M, Ando Y, Kato I, . . . Kojima T (2013) Ribavirin-induced intracellular GTP depletion activates transcription elongation in coagulation factor VII gene expression. Biochem J 449:231-239.
http://www.ncbi.nlm.nih.gov/pubmed/23050902
Thaler J, Ay C, Mackman N, Metz-Schimmerl S, Stift J, Kaider A, . . . Pabinger I (2013) Microparticle-associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features. Eur J Clin Invest 43:277-285.
http://www.ncbi.nlm.nih.gov/pubmed/23398637
Williams FM, Carter AM, Hysi PG, Surdulescu G, Hodgkiss D, Soranzo N, . . . Spector TD (2013) Ischemic stroke is associated with the ABO locus: The EuroCLOT study. Ann Neurol 73:16-31.
http://www.ncbi.nlm.nih.gov/pubmed/23381943
Woo HI, Park IA, Lee KO, Kim SH, Kim HJ (2012) Combined congenital dysfibrinogenemia and factor VII deficiency from mutations in the FGB and F7 genes. Blood Coagul Fibrinolysis 23:355-358.
http://www.ncbi.nlm.nih.gov/pubmed/22576285
Yates KR, Welsh J, Udegbunam NO, Greenman J, Maraveyas A, Madden LA (2012) Duramycin exhibits antiproliferative properties and induces apoptosis in tumour cells. Blood Coagul Fibrinolysis 23:396-401.
http://www.ncbi.nlm.nih.gov/pubmed/22543977
Yuana Y, Osanto S, Bertina RM (2012) Use of immuno-magnetic beads for direct capture of nanosized microparticles from plasma. Blood Coagul Fibrinolysis 23:244-250.
http://www.ncbi.nlm.nih.gov/pubmed/22343682
Zabczyk M, Butenas S, Plicner D, Fijorek K, Sadowski J, Undas A (2012) Factors associated with the presence of circulating active tissue factor and activated factor XI in stable angina patients. Blood Coagul Fibrinolysis 23:189-194.
http://www.ncbi.nlm.nih.gov/pubmed/22343680
Zhang X, Glunz PW, Jiang W, Schmitt A, Newman M, Barbera FA, . . . Scott Priestley E (2013) Design and synthesis of bicyclic pyrazinone and pyrimidinone amides as potent TF-FVIIa inhibitors. Bioorg Med Chem Lett.
http://www.ncbi.nlm.nih.gov/pubmed/23416003
Zhao Y, Fu Y, Hu J, Liu Y, Yin X (2013) The effect of tissue factor pathway inhibitor on the expression of monocyte chemotactic protein-3 and IkappaB-alpha stimulated by tumour necrosis factor-alpha in cultured vascular smooth muscle cells. Arch Cardiovasc Dis 106:4-11.
http://www.ncbi.nlm.nih.gov/pubmed/23374966
Zhou H, Chen D, Xie H, Xia L, Wang T, Yuan W, Yan J (2012) Activation of MAPKs in the anti-beta2GPI/beta2GPI-induced tissue factor expression through TLR4/IRAKs pathway in THP-1 cells. Thromb Res 130:e229-235.
http://www.ncbi.nlm.nih.gov/pubmed/22940059
__________________________________________________________
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
